Bausch Health Companies Inc. announced that the Company was selected as the successful bidder to acquire certain assets of Synergy Pharmaceuticals Inc. for a cash purchase price of approximately $195 million and the assumption of certain assumed...
Read Story
February 28, 2019, 09:00 AM
|
Synergy Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, announced an agreement with Bausch Health Companies Inc., through which Bausch Health would acquire...
Read Story
December 12, 2018, 07:06 AM
|